The Future of Alternative Approaches in Reproductive Toxicity Testing

  • Paul Duffy
  • Stuart Freeman
  • Derek Newall


The remit of this Working Party was to review and assess the current scientific and regulatory requirements in the field of reproductive toxicology. Attention was given to compliance with the Three Rs in current testing methods and the achievement of reduction, refinement and replacement in animal testing by both current methods and research development. This report will comprise three sections covering regulatory aspects, in vitro and in vivo prescreens, and research. Recommendations are listed at the end of each section, and a list of specific recommendations is included at the end of the report, which are directed at industry and the regulatory authorities for their consideration.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kistler, A. (1987). Limb bud cell cultures for estimating the teratogenic potential of compounds: validation of the test with retinoids. Archives of Toxicology 60, 403–414.PubMedCrossRefGoogle Scholar
  2. 2.
    Flint, O.P. & Boyle, F.T. (1985). An in vitro test for teratogens: its application in the selection of non-teratogenic triazole antifungals. Concepts in Toxicology 3, 29–35.Google Scholar
  3. 3.
    Fu, Li-J., Johnson, E.M. & Newman, L.M. (1990). Prediction of the developmental toxicity: hazard potential of halogenate drinking water disinfection by-products tested by the in vitro hydra assay. Regulatory Toxicology and Pharmacology 11, 213–219.PubMedCrossRefGoogle Scholar
  4. 4.
    Phillips, J.C., Gibson, W.B., Yam, J., Alden, C.L. & Hard, G.C. (1990). Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vivo LD50 test. Food and Chemical Toxicology 28, 375–394.PubMedCrossRefGoogle Scholar
  5. 5.
    Kavlock, R.J., Hall, L., Olgesby, L.A., McCoy, M.E. & Copeland, F. (1990). In vivo and in vitro structure-dosimetry-activity relationships and substituted phenols. In Abstracts of the In Vitro Culture of Postimplantation Rodent Embryos Meeting, Louvain-la-Neuve, Belgium, 3–6 April, 1990.Google Scholar
  6. 6.
    Chernoff, N. & Kavlock, R.J. (1990). An in vivo teratology screen utilising pregnant mice. Journal of Toxicology and Environmental Health 10, 541–550.CrossRefGoogle Scholar
  7. 7.
    Wickramaratne, G.A. (1987). The Chernoff-Kavlock assay: its validation and application in rat. Terato genesis, Carcinogenesis, Mutagenesis 7, 73–83.CrossRefGoogle Scholar
  8. 8.
    Hardin, B.D., Becker, R.A., Kavlock, R.J., Seidenberg, J.M. & Chernoff, N. (1987). Overview and summary: workshop on the Chernoff-Kavlock preliminary developmental toxicity test. Teratogenesis, Carcinogenesis, Mutagenesis 7, 119–127.PubMedCrossRefGoogle Scholar
  9. 9.
    Cave, D.A. & Foster, P.M.D. (1990). Modulation of m-dinitrobenzene and m-nitrosonitrobenzene toxicity in rat Sertoli-germ cell co-cultures. Fundamental and Applied Toxicology 14, 199–207.PubMedCrossRefGoogle Scholar
  10. 10.
    Moore, H.D.M. (1986). In vitro manipulation of gametes and embryos for evaluating the effect of chemicals on germ cell function and developmental potential. Food and Chemical Toxicology 24, 607–613.PubMedCrossRefGoogle Scholar
  11. 11.
    Holloway, A.J., Moore, H.D.M. & Foster P.M.D. (1990). The use of in vitro fertilisation to detect reductions in the fertility of male rats exposed to 1,3-dinitrobenzene. Fundamental and Applied Toxicology 14, 113–122.PubMedCrossRefGoogle Scholar
  12. 12.
    Spielmann, H., Kruger, C. & Vogel, R. (1985). Embryotoxicity testing during the pre-implantation period. Concepts in Toxicology 3, 22–28.Google Scholar
  13. 13.
    Freeman, S.J. & Brown, N.A. (1987). Sub-mammalian and sub-vertebrate models in teratogenicity screening. In In Vitro Methods in Toxicology (ed. C.K. Atterwill & C.E. Steel), pp. 391–409. Cambridge: Cambridge University Press.Google Scholar
  14. 14.
    Brown, N.A. (1987). Teratogenicity testing in vitro: status of validation studies. Archives of Toxicology, Suppl. 11, 105–114.Google Scholar
  15. 15.
    Fort, D.J., Dawson, D.A. & Bantle, J.A. (1988). Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutagenesis 8, 251–263.PubMedCrossRefGoogle Scholar
  16. 16.
    Jelinek, R., Peterka, M. & Rychter, Z. (1985). Chick embryotoxicity screening test—130 substances tested. Indian Journal of Experimental Biology 23, 588–595.PubMedGoogle Scholar
  17. 17.
    Bechter, R. & Schmid, B.P. (1987). Teratogenicity in vitro: a comparative study of four antimycotic drugs using the whole-embryo culture system. Toxicology in Vitro 1, 11–15.Google Scholar
  18. 18.
    Cicurel, L. & Schmid, B.P. (1988). Postimplantation embryo culture for the assessment of teratogenic potential and potency of compounds. Experientia 44, 833–840.PubMedCrossRefGoogle Scholar
  19. 19.
    Piersma, A.H., Attenon, J., Govers, M.J.A.P., Peters, P.W.J., Picard J.J., Schimdt, B.P., Stadler, J., Van Maele-Fabry, G., Verhoef, A. & Verseil, C. (1990). Rodent postimplantation embryo culture: interlaboratory validation as a screening test for teratogenic compounds. In Abstracts of the In Vitro Culture of Postimplantation Rodent Embryos Meeting, Louvain-la-Neuve, Belgium, 3–6 April, 1990.Google Scholar
  20. 20.
    Wiger, R., Stottum, A. & Brunborg, G. (1988). Estimating chemical developmental hazard in a chicken embryo limb bud micromass system. Pharmacology and Toxicology 2, 32–37.CrossRefGoogle Scholar
  21. 21.
    Hassel, J.R. & Horigan, E.A. (1982). Chondrogenesis: a model developmental system for measuring teratogenic potential of compounds. Teratogenesis, Carcinogenesis, Mutagenesis 2, 325–331.CrossRefGoogle Scholar
  22. 22.
    Wise, L.D., Clark, R.L., Rundell, J.O. & Robertson, R.T. (1990). Examination of a rodent limb bud micromass assay as a screen for developmental toxicity. Teratology 41, 341–351.PubMedCrossRefGoogle Scholar
  23. 23.
    Kistler, A. (1985). Inhibition of chondrogenesis by retinoids: limb bud cell cultures as a test system to measure the teratogenic potential of compounds. Concepts Toxicology 3, 86–100.Google Scholar
  24. 24.
    Renault, J-Y., Melcion, C. & Cordier, A. (1989). Limb bud cell culture for in vitro teratogen screening: validation of an improved assessment method using 51 compounds. Teratogenesis, Carcinogenesis, Mutagenesis 9, 83–96.PubMedCrossRefGoogle Scholar
  25. 25.
    Flint, O.P. & Orton, T.C. (1984). An in vitro assay for teratogens with cultures of rat embryo mid-brain and limb bud cells. Toxicology and Applied Pharmacology 76, 383–395.PubMedCrossRefGoogle Scholar
  26. 26.
    Steele, V.E., Morrissey, R.E., Elmore, E.L., Rocha, D.G., Wilkinson, B.P., Curren, R.D., Schmetter, B.S., Louie, A.T., Lamb, J.C. & Yang, L.L. (1988). Evaluation of two in vitro assays to screen for potential development toxicants. Fundamental and Applied Toxicology 11, 673–684.PubMedCrossRefGoogle Scholar
  27. 27.
    Smith, M.K., Kimmel, G.L., Kochhas, D.M., Shephard, T.H., Spielberg, S.P. & Wilson, J.G. (1983). A selection of candidate compounds for in vitro teratogenesis test validation. Teratogenesis, Carcinogenesis, Mutagenesis 3, 461–480.PubMedCrossRefGoogle Scholar
  28. 28.
    Johnson, E.M., Newman, L.M. & Giacobbi, R.L. (1990). Some fundamental problems with in vitro developmental toxicity prescreeing assays as illustrated with bean seedlings. Teratology 41, 568.Google Scholar
  29. 29.
    Uphill, P.F., Wilkins, S.R. & Allen, J.A. (1990). In vitro micromass teratogen test results from a blind trial of 25 compounds and the effects of differing S9 treatment regimes on response to cyclophosphamide. Toxicology in Vitro, in press.Google Scholar
  30. 30.
    New, D.A.T. (1978). Whole-embryo culture and the study of mammalian embryos during organogenesis. Biological Review 53, 81–122.CrossRefGoogle Scholar
  31. 31.
    Rogers, J.M., Daston, G.P. & Ebron, M.T. (1985). Studies on the mechanism of trypan blue teratogenesis in the rat developing in vivo and in vitro. Teratology 31, 389–399.Google Scholar
  32. 32.
    Brown, N.A., Farmer, P.B. & Coakley, M.E. (1985). Valproic acid teratogenesis: demonstration that the biochemical mechanism differs from that of valproate hepatoxicity. Biochemical Society Transactions 13, 75–77.PubMedCrossRefGoogle Scholar
  33. 33.
    Coakley, M.E., Rawlings, S.J. & Brown N.A. (1987). Short-chain carboxylic acids, a new class of teratogens: studies of potential biochemical mechanisms. Environmental Health Perspectives. Google Scholar
  34. 34.
    Spielmann, H. & Vogel, R. (1989). Unique role of studies on pre-implantation embryos to understand mechanisms of embryotoxicity in early pregnancy. Critical Reviews in Toxicology 20, 51–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Welsh, F., ed. (1987). Approaches to Elucidate Mechanisms in Teratogenesis, 285 pp. Washington, DC: Hemisphere.Google Scholar
  36. 36.
    Nau, H. (1990). Pharmacokinetic aspects of in vitro teratogenicity studies: comparison to in vivo. In In Vitro Methods in Developmental Toxicology (ed. G.L. Kimmel & D.M. Kochhar), pp. 29–43. Boca Ratan, FL, USA: CRC Press.Google Scholar
  37. 37.
    Feuston, M.H. & Scott W.J. (1985). Cadmium-induced forelimb ectrodactyly: a proposed mechanism of teratogenesis. Teratology 32, 407–419.PubMedCrossRefGoogle Scholar
  38. 38.
    Pratt, R.M. (1985). Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate. Environmental Health Perspectives 61, 35–40.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Honda, A., Iwama, M., Umeda, T. & Mori, Y. (1982). The teratogenic mechanism of 6-aminonicotinamide on limb formation of chick embryos: abnormalities in the biosynthesis of glycosaminoglycans and proteoglycans in micromelia. Journal of Biochemistry 91, 1959–1970.PubMedGoogle Scholar
  40. 40.
    Loch-Caruso, R. (1990). Application of cell-cell communication assays to problems of developmental toxicology. In In Vitro Methods in Developmental Toxicology (ed. G.L. Kimmel & D.M. Kochhar), 45–67. Boca Ratan, FL, USA: CRC Press.Google Scholar
  41. 41.
    Horton, W.E., Cleveland J., Rapp, U., Kohno, K., Yamada, Y., Miyashita, T. & Hasell, J.R. (1990). The regulation of genes encoding extracellular matrix proteins: in vitro studies and relationships to teratogenic mechanisms. In In Vitro Methods in Developmental Toxicology (ed. G.L. Kimmel & D.M. Kochhar), pp. 143–161. Boca Ratan, FL, USA: CRC Press.Google Scholar
  42. 42.
    Knudsen, T.B. (1990). In vitro approaches to the study of embryonic cell death in developmental toxicology. In In Vitro Methods in Developmental Toxicology (ed. G.L. Kimmel & D.M. Kochhor), 129–142. Boca Ratan, FL, USA: CRC Press.Google Scholar
  43. 43.
    Scott, W.J., Duggan, C.A., Schreiner, C.M. & Collins, M.D. (1990). Reduction of embryonic intracellular pH: a potential mechanism of acetazolamide-induced limb malformations. Toxicology and Applied Pharmcology 103, 238–254.CrossRefGoogle Scholar
  44. 44.
    Ranganathan, S., Churchill, P.F. & Hood, R.D. (1989). Inhibition of mitochondrial respiration of cationic rhodamines as a possible teratogenicity mechanism. Toxicology and Applied Pharmacology 99, 81–89.PubMedCrossRefGoogle Scholar
  45. 45.
    Fantel, A.G., Juchau, M.R., Tracey, J.W., Burrows, C.J. & Person, R.E. (1989). Studies of the mechanisms of niridazole-elicited embryotoxicity: evidence against a major role for covalent binding. Teratology 39, 63–74.PubMedCrossRefGoogle Scholar
  46. 46.
    Boeklheide, M., Neeley, D. & Sioussat, T M. (1989). The Sertoli cell cytoskeleton: a target for toxicant-induced germ cell loss. Toxicology and Applied Pharmacology 101, 373–389.CrossRefGoogle Scholar
  47. 47.
    Platzek, T., Meister, R., Chahoud, I., Bochert, G., Krowke, R. & Neubert, D. (1987). Studies on the mechanisms of dose-response relationships. In Approaches to Elucidate the Mechanisms in Teratogenesis (ed. F. Welsch), 59–81. Washington, DC, USA: Hemisphere.Google Scholar

Copyright information

© FRAME 1991

Authors and Affiliations

  • Paul Duffy
    • 1
  • Stuart Freeman
    • 1
  • Derek Newall
    • 2
  1. 1.Safety of MedicinesICI Pharmaceuticals DivisionMacclesfieldUK
  2. 2.Glaxo Group Research LtdWareUK

Personalised recommendations